NCT00291967View on ClinicalTrials.gov

Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

525

Participants

Timeline

Start Date

November 30, 2002

Conditions
DiphtheriaTetanusPertussisHepatitis BHib DiseasesNeisseria Meningitidis Serogroups A & C Diseases
Interventions
BIOLOGICAL

DTPw-HBV/Hib-MenAC conjugate vaccine

Trial Locations (1)

Unknown

Manila

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY